InvestorsHub Logo
Followers 29
Posts 468
Boards Moderated 0
Alias Born 02/02/2017

Re: whento post# 58574

Saturday, 10/14/2017 9:17:20 AM

Saturday, October 14, 2017 9:17:20 AM

Post# of 205098
Ten Reasons To Invest in Silicon Valley Biotech Company, Arrayit Corporation $ARYC):

1. $ARYC @Arrayit on Twitter......Trading at .01 per share and headquartered in the heart of Silicon Valley. @arrayit on Twitter and Arrayit Corporation on Facebook. The company's in the final stages of an intensive audit and is set to release financials soon.

2. Arrayit Corporation is a leading edge developer, manufacturer and marketer of next-generation life science tools and integrated systems for the large-scale analysis of genetic variation, biological function and diagnostics. Using Arrayit’s proprietary technologies, the Company provides a comprehensive line of products and services that currently serve the sequencing, genotyping, gene expression and protein analysis markets, and the Company expects to enter the market for molecular diagnostics.

3. Arrayit has earned respect as a leader in the healthcare and life sciences industries with its proven expertise in three key areas: the development and support of microarray tools and components, custom printing and analysis of microarrays for research, and the identification and development of diagnostic microarrays and tools for early detection of treatable disease states.
4. Arrayit has provided tools and services to thousands of the leading genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, government agencies and biotechnology companies worldwide.
5. The Company’s patented tools and trade secrets provide researchers around the world with the performance, throughput, cost effectiveness and flexibility necessary to perform the billions of genetic tests needed to extract valuable medical information. The Company believes this information will enable researchers to correlate genetic variation and biological function, which will enhance drug discovery, drug development and clinical research, allowing diseases to be detected earlier and permitting better choices of drugs for individual patients.
6. Estimated revenues last year of over $8 million !!

7. Sales reported at $40,000+ every day !!!

8. Low float of 696m as of 3-31-17 per OTC and no increase in float or OS since 2015

9. The company is open to shareholders visiting:
927 Thompson Place
Sunnyvale, CA 94085
USA

(Apple, Google, Linkdin, AMD, Lockheed, Yahoo, Juniper and many many more high tech companies are its close by neighbors)

10. This is NOT a P&D company. This is a stock to accumulate for generational wealth. Buying shares sub-penny currently and holding will create immense wealth. There is no reason that it should not be trading over $1 per share. There are no promotions, no paid pumping, ARYC is a real company that is working its way back to the Nasdaq.